Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$3.90
—
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
Implied Upside
+156.4%
Consensus $10.00 vs current $3.90
NASDAQ·Healthcare·Biotechnology
$3.90
—
Mkt Cap $27.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
+156.4%
Consensus $10.00 vs current $3.90